ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.278,99
0,62%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Adeona Pharmaceuticals Common Stock (AEN)

  7. Adeona Pharmaceuticals Common Stock (AEN) News

AEN

Adeona Pharmaceuticals Common Stock (AEN)

Adeona Pharmaceuticals Common Stock
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:AEN
DatumZeitQuelleÜberschriftSymbolFirma
16/02/201212h30PR Newswire (US)Adeona Becomes Synthetic Biologics, Inc.AMEX:AENAdeona Pharmaceuticals Common Stock
13/02/201223h02Edgar (US Regulatory)Current report filing (8-K)AMEX:AENAdeona Pharmaceuticals Common Stock
09/02/201222h33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:AENAdeona Pharmaceuticals Common Stock
09/02/201221h32PR Newswire (US)Adeona CEO to Present at the Harvard Investors Group ForumAMEX:AENAdeona Pharmaceuticals Common Stock
07/02/201221h31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:AENAdeona Pharmaceuticals Common Stock
07/02/201221h30Edgar (US Regulatory)Current report filing (8-K)AMEX:AENAdeona Pharmaceuticals Common Stock
07/02/201212h30PR Newswire (US)Adeona Appoints C. Evan Ballantyne as Chief Financial OfficerAMEX:AENAdeona Pharmaceuticals Common Stock
07/02/201203h42Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:AENAdeona Pharmaceuticals Common Stock
06/02/201222h51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:AENAdeona Pharmaceuticals Common Stock
06/02/201222h22Edgar (US Regulatory)Current report filing (8-K)AMEX:AENAdeona Pharmaceuticals Common Stock
06/02/201212h30PR Newswire (US)Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Company's Synthetic Biolo...AMEX:AENAdeona Pharmaceuticals Common Stock
03/02/201212h03Edgar (US Regulatory)Amended Current report filing (8-K/A)AMEX:AENAdeona Pharmaceuticals Common Stock
26/01/201212h01Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:AENAdeona Pharmaceuticals Common Stock
19/01/201212h30PR Newswire (US)Adeona Announces Initiation of Phase II Clinical Trial of Trimesta™ for Cognitive Dysfunction in Multiple SclerosisAMEX:AENAdeona Pharmaceuticals Common Stock
04/01/201212h02Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:AENAdeona Pharmaceuticals Common Stock
21/12/201112h30PR Newswire (US)Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice Pr...AMEX:AENAdeona Pharmaceuticals Common Stock
21/12/201112h02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)AMEX:AENAdeona Pharmaceuticals Common Stock
12/12/201123h26Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)AMEX:AENAdeona Pharmaceuticals Common Stock
08/12/201118h33Edgar (US Regulatory)Current report filing (8-K)AMEX:AENAdeona Pharmaceuticals Common Stock
01/12/201110h12ZacksCompany News for December 01, 2011 - Corporate SummaryAMEX:AENAdeona Pharmaceuticals Common Stock
30/11/201112h30PR Newswire (US)Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS CollaboratorAMEX:AENAdeona Pharmaceuticals Common Stock
21/11/201123h08Edgar (US Regulatory)Current report filing (8-K)AMEX:AENAdeona Pharmaceuticals Common Stock
21/11/201118h30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:AENAdeona Pharmaceuticals Common Stock
21/11/201112h30PR Newswire (US)Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary ...AMEX:AENAdeona Pharmaceuticals Common Stock
14/11/201122h07Edgar (US Regulatory)Current report filing (8-K)AMEX:AENAdeona Pharmaceuticals Common Stock
14/11/201122h05Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:AENAdeona Pharmaceuticals Common Stock
14/11/201115h00PR Newswire (US)Adeona Reports Third Quarter 2011 Financial ResultsAMEX:AENAdeona Pharmaceuticals Common Stock
11/11/201115h00PR Newswire (US)Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis ResearchAMEX:AENAdeona Pharmaceuticals Common Stock
09/11/201120h00PR Newswire (US)Adeona to Host Third Quarter 2011 Investor Conference CallAMEX:AENAdeona Pharmaceuticals Common Stock
08/11/201120h00PR Newswire (US)Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual MeetingAMEX:AENAdeona Pharmaceuticals Common Stock
 Showing the most relevant articles for your search:AMEX:AEN

Kürzlich von Ihnen besucht

NASDAQ
MSFT
Microsoft
USOTC
RHHBY
Roche (QX)
TG
DTE
Deutsche Telekom
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
DBK
Deutsche Bank
TG
ALV
Allianz
TG
D7G
Nel ASA
USOTC
ADDYY
Adidas (QX)
TG
BAS
BASF
NASDAQ
NVDA
NVIDIA
TG
LHA
Deutsche Lufthansa
TG
RHM
Rheinmetall
COIN
BTCUSD
Bitcoin
AMEX
XLF
Financial Select Sector
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten